Search

everythinglearnresearchcommunity

for

Search:↓

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

Memantine may slightly improve memory in people with Down syndrome, but more research is needed.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Tamoxifen caused hair loss in a 52-year-old woman.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.